![]() |
![]() |
(S)-3-Amino-4-(((S)-1-methoxy-1-oxo-3-phenylpropan-2-yl)amino)-4-oxobutanoic acid 3-Amino-N-(a-carboxyphenethyl)succinamic Acid N-Methyl Ester APM ASPARTAM Aspartylphenylalanine methyl ester Aspertame Asp-Phe methyl ester Asp-Phe-OMe Asp-Phe-OMe H-Asp-Phe-OMe N-(L-α-Aspartyl)-L-phenylalanine methyl ester N-L-alpha-Aspartyl-L-phenylalanine 1-Methyl Ester L-Aspartyl-L-phenylalanine methyl ester Canderel c-mer E 951 E962 EINECS 245-261-3 Equal H-Asp-Phe-OMe L-ASPARTYL-L-PHENYLALANINE METHYL ESTER L-ASP-PHE METHYL ESTER L-phenylalanine, L-a-aspartyl-, methyl ester L-Phenylalanine, L-α-aspartyl-, methyl ester mer methyl L-a-aspartyl-L-phenylalaninate Methyl L-α-aspartyl-L-phenylalaninate Methyl N-L-α-aspartyl-L-phenylalaninate MFCD00002724 Monoclonal Anti-MERTK antibody produced in mouse N-(L-α-Aspartyl)-L-phenylalanine methyl ester N-L-a-Aspartyl-L-phenylalanine-1-Methyl Ester N-L-α-Aspartyl-L-phenylalanine 1-Methyl Ester NutraSweet RP38 tri-sweet Zero-Cal Β-Aspartame
2-8℃
Human systemic effects by ingestion: allergic dermatitis. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.
Safety Statements?of Aspartame (CAS NO.22839-47-0): 22-24/25?
S22: Do not breathe dust.?
S24/25: Avoid contact with skin and eyes.
WGK Germany: 2
The artificial sweetener Aspartame (CAS NO.22839-47-0) has been the subject of controversy since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. Concerns have been raised about the quality of the research supporting its safety and the long-term effects that increased consumption could have on the public.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | > 5gm/kg (5000mg/kg) | ? | Toksikologicheskii Vestnik. Vol. (3), Pg. 37, 1996. |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | ? | Toksikologicheskii Vestnik. Vol. (3), Pg. 37, 1996. |
rat | LD50 | intraperitoneal | > 5gm/kg (5000mg/kg) | ? | Toksikologicheskii Vestnik. Vol. (3), Pg. 37, 1996. |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | ? | Toksikologicheskii Vestnik. Vol. (3), Pg. 37, 1996. |
women | TDLo | oral | 3710ug/kg (3.71mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" | Annals of Internal Medicine. Vol. 104, Pg. 207, 1986. |
Not classified.
Pictogram(s) | No symbol. |
---|---|
Signal word | No signal word. |
Hazard statement(s) | none |
Precautionary statement(s) | |
Prevention | none |
Response | none |
Storage | none |
Disposal | none |
none
![]() |
![]() |
![]() |